Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0EQ9T
|
||||
| Former ID |
DIB012073
|
||||
| Drug Name |
JNJ-39220675
|
||||
| Synonyms |
Histamine H3 receptor antagonist (allergic rhinitis/alcoholism), Johnson & Johnson
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Alcohol use disorders [ICD9: 303; ICD10:F10.2] | Phase 2 | [1] | ||
| Company |
Johnson & Johnson Pharmaceutical Research & Development LLC
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H24FN3O2
|
||||
| Canonical SMILES |
C1CC(C1)N2CCCN(CC2)C(=O)C3=CN=C(C=C3)OC4=CC=C(C=C4)F
|
||||
| InChI |
1S/C21H24FN3O2/c22-17-6-8-19(9-7-17)27-20-10-5-16(15-23-20)21(26)25-12-2-11-24(13-14-25)18-3-1-4-18/h5-10,15,18H,1-4,11-14H2
|
||||
| InChIKey |
IQOWHZHNGJXGHG-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Histamine H3 receptor | Target Info | Antagonist | [2] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Reactome | Histamine receptors | ||||
| G alpha (i) signalling events | |||||
| WikiPathways | Monoamine Transport | ||||
| GPCRs, Class A Rhodopsin-like | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00804687) An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis. U.S. National Institutes of Health. | ||||
| REF 2 | JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology (Berl). 2011 Apr;214(4):829-41. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.